Study on T1 Ampullary Cancer Outcomes Guides Surgical Decisions

Surgeons treating T1 ampullary cancer need to consider high upstaging rates and significant survival disparities based on pathologic classification.

In this cohort of 244 T1 ampullary cancer patients, 75% underwent resection, but 68% were upstaged to higher T classifications post-surgery.
Five-year overall survival rates were starkly different: 36% for clinical T1N0 vs. 75% for pathologic T1N0 patients.

Given these findings, pancreatoduodenectomy is recommended over local resection for better outcomes.

Independent predictors for poor survival include pathologic N1 (HR: 2.12) and poorly differentiated tumors (HR: 4.05).

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.